| Financial Year |
March 31 2023 |
| Monetary Funds |
1,213,861,612.24 |
| Held-for-trading Financial Assets |
105,756.28 |
| Notes Receivable |
695,642,568.79 |
| Accounts Receivable |
389,919,294.08 |
| Advances to Suppliers |
1,956,407,468.13 |
| Other Receivables |
20,799,872.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,096,764,097.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,009,583.34 |
| Total Current Assets |
6,400,404,560.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
47,035,636.94 |
| Investment Properties |
7,703,672.90 |
| Fixed Assetes |
9,005,456,710.82 |
| Under-construction Projects |
60,448,838.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
695,007,003.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,178,114.94 |
| Deferred Income Tax Assets |
100,703,637.46 |
| Other Non-Current Assets |
332,590,455.66 |
| Sub-Total of Non-Current Assets |
10,262,335,916.51 |
| Total Assets |
16,662,740,476.99 |
| Short-Term Loans |
4,309,185,167.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
683,868,222.00 |
| Accounts Payable |
1,689,582,547.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
154,994,799.38 |
| Taxes Payable |
343,079,556.71 |
| Interest Payable |
-- |
| Dividend Payable |
31,991,266.59 |
| Other payables |
1,190,926,573.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,202,268,994.86 |
| Other Current Liabilities |
890,553,619.17 |
| Sub-Total of Current Liabilities |
14,850,722,623.28 |
| Long-term Loans |
824,250,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
230,470,901.56 |
| Special Payable |
-- |
| Estimatied Liabilities |
18,199,690.00 |
| Deferred Income Tax Liabilities |
552,961.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,619,790,924.92 |
| Total Liabilities |
16,470,513,548.20 |
| Paid-In Capital(Or Share Stock) |
1,045,118,252.00 |
| Capital Surplus |
2,212,433,394.75 |
| Surplus Reserve |
192,877,289.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-4,580,757,137.19 |
| Minority Stockholder's Interest |
1,291,741,223.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-1,099,514,294.91 |
| Owner's Equity（Stockholder's Equity） |
192,226,928.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,662,740,476.99 |
